Advertisement
News
Advertisement

Patient-founded DART Therapeutics names CEO, other execs

Mon, 09/10/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

DART Therapeutics isn’t your ordinary therapeutics business. The Cambridge therapeutics startup focused on treatments for Duchenne muscular dystrophy(DMD), a fatal neuromuscular disorder with no current treatment affecting one in 3,500 boys worldwide, has made several new executive appointments to its leadership team.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading